SouthViews No. 195, 14 May 2020
COVID-19: An Opportunity to Fix Dysfunctional Biomedical R&D System
By Sreenath Namboodiri
Failures of the patent system to meet the public health priorities demand a new approach in research and development (R&D) financing and incentive to pharmaceutical innovations. An R&D model delinking the cost of R&D from the price of the product is the way forward.
Download the SouthViews below:
COVID-19: An Opportunity to Fix Dysfunctional Biomedical R&D System
This article was tagged: Access to Medicines, Coronavirus, COVID-19, Health, India, Innovation, Intellectual Property, International Covenant on Economic Social and Cultural Rights (ICESCR), Pandemic, Patent, Pharmaceuticals, Public Health, Research and Development (R&D), Vaccines
